HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of the SQ-standardized grass allergy immunotherapy tablet in mono- and polysensitized subjects.

Abstract
The efficacy of single-allergen-specific immunotherapy in polysensitized subjects is a matter of debate. We therefore performed a post hoc analysis of pooled data from six randomized, double-blind, placebo-controlled trials (N = 1871) comparing the efficacy and safety of the SQ-standardized grass allergy immunotherapy tablet (AIT), Grazax (Phleum pratense 75 000 SQ-T/2800 BAU, ALK, Denmark), in mono- and polysensitized subjects. A statistically significant reduction in the mean total combined symptom/medication score (TCS) of 27% was demonstrated in actively treated subjects compared with placebo (P < 0.0001). This was not dependent on sensitization status (P = 0.5772), suggesting a similar treatment effect in mono- and polysensitized subjects (i.e. reductions of the TCSs of 28% and 26%, respectively, both P < 0.0001). Finally, a comparable and favourable safety profile of grass AIT was demonstrated in the two subgroups. Thus, no difference in efficacy and safety of single-allergen grass AIT was observed between mono- and polysensitized subjects.
AuthorsH Nelson, M Blaiss, H Nolte, S Ø Würtz, J S Andersen, S R Durham
JournalAllergy (Allergy) Vol. 68 Issue 2 Pg. 252-5 (Feb 2013) ISSN: 1398-9995 [Electronic] Denmark
PMID23205670 (Publication Type: Comparative Study, Evaluation Study, Journal Article)
Copyright© 2012 John Wiley & Sons A/S.
Chemical References
  • Antigens, Plant
  • Grazax
  • Plant Extracts
  • Tablets
Topics
  • Administration, Sublingual
  • Adult
  • Antigens, Plant (immunology)
  • Child
  • Child, Preschool
  • Desensitization, Immunologic (methods)
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Patient Safety
  • Phytotherapy (methods)
  • Plant Extracts (therapeutic use)
  • Poaceae (immunology)
  • Randomized Controlled Trials as Topic
  • Rhinitis, Allergic, Seasonal (drug therapy, immunology, physiopathology)
  • Risk Assessment
  • Severity of Illness Index
  • Tablets (administration & dosage)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: